Analystreport

Axsome Therapeutics Inc (NASDAQ: AXSM) had its price target raised by analysts at BTIG Research to $20.00. They now have a "buy" rating on the stock.

Axsome Therapeutics, Inc.  (AXSM) 
Last axsome therapeutics, inc. earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: axsome.com